DHDongmei Han

Dongmei Han

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dongmei Han has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Zhen Wang

    Zhejiang Key Laboratory of Signaling Mechanisms in Tumor Progression and Intervention School of Life Science Hangzhou Institute for Advanced Study University of Chinese Academy of Sciences Hangzhou China

    2 shared publications
  • Linxiao Wang

    CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences , 320 Yueyang Road, Shanghai, 200031 , China

    1 shared publication
  • Sijia Wang

    Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China

    1 shared publication
  • Wenran Li

    CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China

    1 shared publication
  • Wenwen Zhang

    Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences , Shanghai 200031

    1 shared publication
  • Xuan Liang

    CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences , 320 Yueyang Road, Shanghai, 200031 , China

    1 shared publication

Latest Publications

  • Open Access

    Predicting enhancer–gene links from single-cell multi-omics data by integrating prior Hi-C information

    by Xuan Liang, Yuanyuan Miao, Dongmei Han, Yurun Li, Wenwen Zhang, Zhen Wang

    Enhancers play an important role in transcriptional regulation by modulating gene expression from distal genomic locations. Although single-cell ATAC and RNA sequencing (scATAC/RNA-seq) data have been leveraged to infer enhancer–gene links, establishing regulatory links between enhancers and their target genes remains a challenge due to the absence of chromatin conformation information. Here, we present SCEG-HiC, a machine learning method based on weighted graphical lasso, which decodes enhancer–gene links from single-cell multi-omics data by integrating bulk average Hi-C as prior knowledge. SCEG-HiC supports both paired scATAC/RNA-seq and scATAC-only inputs, improving prediction accuracy while retaining context-specific correlations and enabling the discovery of biologically relevant links. Comprehensive evaluation across 10 human and mouse single-cell multi-omics datasets shows that SCEG-HiC outperforms existing single-cell models. Application of SCEG-HiC to COVID-19 datasets illustrates its capacity to more reliably reconstruct gene regulatory networks underlying disease severity, and elucidate functional associations between noncoding variants and their putative target genes. SCEG-HiC is freely available as an open-source and user-friendly R package, facilitating broad applications in regulatory genomics research.


  • Open Access

    Comparative analysis of models in predicting the effects of SNPs on TF-DNA binding using large-scale in vitro and in vivo data

    by Dongmei Han, Yurun Li, Linxiao Wang, Xuan Liang, Yuanyuan Miao, Wenran Li, Sijia Wang, Zhen Wang

    Non-coding variants associated with complex traits can alter the motifs of transcription factor (TF)–deoxyribonucleic acid binding. Although many computational models have been developed to predict the effects of non-coding variants on TF binding, their predictive power lacks systematic evaluation. Here we have evaluated 14 different models built on position weight matrices (PWMs), support vector machines, ordinary least squares and deep neural networks (DNNs), using large-scale in vitro (i.e. SNP-SELEX) and in vivo (i.e. allele-specific binding, ASB) TF binding data. Our results show that the accuracy of each model in predicting SNP effects in vitro significantly exceeds that achieved in vivo. For in vitro variant impact prediction, kmer/gkm-based machine learning methods (deltaSVM_HT-SELEX, QBiC-Pred) trained on in vitro datasets exhibit the best performance. For in vivo ASB variant prediction, DNN-based multitask models (DeepSEA, Sei, Enformer) trained on the ChIP-seq dataset exhibit relatively superior performance. Among the PWM-based methods, tRap demonstrates better performance in both in vitro and in vivo evaluations. In addition, we find that TF classes such as basic leucine zipper factors could be predicted more accurately, whereas those such as C2H2 zinc finger factors are predicted less accurately, aligning with the evolutionary conservation of these TF classes. We also underscore the significance of non-sequence factors such as cis-regulatory element type, TF expression, interactions and post-translational modifications in influencing the in vivo predictive performance of TFs. Our research provides valuable insights into selecting prioritization methods for non-coding variants and further optimizing such models.